Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Nuklearmedizin. Nuclear Medicine|February 13, 2009
[Radiation exposure in the environment of patients after application of radiopharmaceuticals. Part 2: Therapeutic procedures]F Sudbrock, F Boldt, C Kobe, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|March 5, 2011
Extra-adrenal pheochromocytoma in the organ of Zuckerkandl: diagnosis and treatment strategiesD Kahraman, P E Goretzki, M Szangolies, et al.
Nuklearmedizin. Nuclear Medicine|February 19, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the achieved dose above 200 Gy?C Kobe, W Eschner, F Sudbrock, et al.
Nuklearmedizin. Nuclear Medicine|August 12, 2008
Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication?C Kobe, I Weber, W Eschner, et al.
Nuklearmedizin. Nuclear Medicine|September 4, 2012
Calcitonin screening in patients with thyroid nodules. Diagnostic valueC Schneider, C Kobe, M Schmidt, et al.
ACS Combinatorial Science|January 9, 2019
Cellular-Based Selections Aid Yeast-Display Discovery of Genuine Cell-Binding Ligands: Targeting Oncology Vascular Biomarker CD276Lawrence A Stern, Patrick S Lown, Alexandra C Kobe, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 12, 2012
Large mediastinal tumor mass as a prognostic factor in Hodgkin's lymphoma. Is the definition on the basis of a chest radiograph in the era of CT obsolete?J Kriz, R-P Mueller, H Mueller, et al.
Nuklearmedizin. Nuclear Medicine|December 6, 2008
[FDG-PET in Hodgkin lymphoma]C Kobe, M Dietlein, C Mauz-Körholz, et al.
Pageof 4